{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:45:27Z","timestamp":1762321527455},"reference-count":31,"publisher":"Europa Digital & Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.4244\/eijv10i1a14","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T05:38:19Z","timestamp":1405661899000},"page":"83-89","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes"],"prefix":"10.4244","volume":"10","author":[{"given":"Gjin","family":"Ndrepepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"P\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Pache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2014513121715-0","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.","volume":"27","author":"Wild S.","year":"2004","journal-title":"Diabetes Care."},{"key":"key-2014513121715-1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0735-1097(00)00732-4","article-title":"Management of coronary artery disease: therapeutic options in patients with diabetes.","volume":"36","author":"Hammoud T.","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-2","first-page":"654","article-title":"Revascularisation of coronary artery disease in patients with diabetes mellitus.","volume":"139","author":"Cook S.","year":"2009","journal-title":"Swiss Med Wkly."},{"key":"key-2014513121715-3","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1161\/01.CIR.0000013957.30622.05","article-title":"Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients.","volume":"105","author":"Smith SC Jr.","year":"2002","journal-title":"Circulation."},{"key":"key-2014513121715-4","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.jacc.2012.08.993","article-title":"Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.","volume":"60","author":"Hillegass WB.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.","volume":"154","author":"Iijima R.","year":"2007","journal-title":"Am Heart J."},{"key":"key-2014513121715-6","doi-asserted-by":"publisher","first-page":"a1331","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.","volume":"337","author":"Stettler C.","year":"2008","journal-title":"BMJ."},{"key":"key-2014513121715-7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.amjcard.2011.11.046","article-title":"Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS-AMI).","volume":"109","author":"Brener SJ.","year":"2012","journal-title":"Am J Cardiol."},{"key":"key-2014513121715-8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.amjcard.2007.06.026","article-title":"Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial.","volume":"100","author":"Feit F.","year":"2007","journal-title":"Am J Cardiol."},{"key":"key-2014513121715-9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.","volume":"49","author":"Manoukian SV.","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.","volume":"51","author":"Ndrepepa G.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","article-title":"Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.","volume":"4","author":"Mehran R.","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2014513121715-12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.","volume":"350","author":"Kastrati A.","year":"2004","journal-title":"N Engl J Med."},{"key":"key-2014513121715-13","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1161\/01.CIR.0000148956.93631.4D","article-title":"Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.","volume":"110","author":"Mehilli J.","year":"2004","journal-title":"Circulation."},{"key":"key-2014513121715-14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2796.2004.01398.x","article-title":"A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.","volume":"256","author":"Hausleiter J.","year":"2004","journal-title":"J Intern Med."},{"key":"key-2014513121715-15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.","volume":"295","author":"Kastrati A.","year":"2006","journal-title":"JAMA."},{"key":"key-2014513121715-16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.","volume":"359","author":"Kastrati A.","year":"2008","journal-title":"N Engl J Med."},{"key":"key-2014513121715-17","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1093\/eurheartj\/ehq330","article-title":"ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.","volume":"31","author":"Schulz S.","year":"2010","journal-title":"Eur Heart J."},{"key":"key-2014513121715-18","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.","volume":"365","author":"Kastrati A.","year":"2011","journal-title":"N Engl J Med."},{"key":"key-2014513121715-19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft DW.","year":"1976","journal-title":"Nephron."},{"key":"key-2014513121715-20","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran R.","year":"2011","journal-title":"Circulation."},{"key":"key-2014513121715-21","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-2014513121715-22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch PM.","year":"1994","journal-title":"Biometrika."},{"key":"key-2014513121715-23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina MJ.","year":"2008","journal-title":"Stat Med."},{"key":"key-2014513121715-24","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes.","volume":"307","author":"De Berardis G.","year":"2012","journal-title":"JAMA."},{"key":"key-2014513121715-25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","article-title":"Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.","volume":"125","author":"Ndrepepa G.","year":"2012","journal-title":"Circulation."},{"key":"key-2014513121715-26","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.","volume":"53","author":"Doyle BJ.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.23200","article-title":"Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: clinical outcomes and prognostic value of abdominal\/pelvic computed tomography.","volume":"80","author":"Maluenda G.","year":"2012","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2014513121715-28","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer FA.","year":"2007","journal-title":"Circulation."},{"key":"key-2014513121715-29","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2004.07.060","article-title":"New aspects in the pathogenesis of diabetic atherothrombosis.","volume":"44","author":"Moreno PR.","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"key-2014513121715-30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jcin.2010.10.011","article-title":"Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.","volume":"4","author":"Verheugt FW.","year":"2011","journal-title":"JACC Cardiovasc Interv."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T05:38:59Z","timestamp":1405661939000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/72nd_issue\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["20130502-03"],"URL":"https:\/\/doi.org\/10.4244\/eijv10i1a14","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}